MACK Annual Accounts Receivable
N/A
31 December 2023
Summary:
MACK annual accounts receivable is not available.MACK Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MACK Quarterly Accounts Receivable
N/A
01 March 2024
Summary:
MACK quarterly accounts receivable is not available.MACK Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MACK Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
MACK Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time |
Merrimack Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $100.00 K(-63.6%) | $100.00 K(-47.4%) |
| Sept 2017 | - | $190.00 K(+341.9%) |
| June 2017 | - | $43.00 K(0.0%) |
| Mar 2017 | - | $43.00 K(-84.4%) |
| Dec 2016 | $275.00 K(-95.8%) | $275.00 K(-98.8%) |
| Sept 2016 | - | $22.17 M(+14.7%) |
| June 2016 | - | $19.32 M(+23.6%) |
| Mar 2016 | - | $15.64 M(+141.2%) |
| Dec 2015 | $6.48 M(+95.7%) | $6.48 M(+216.1%) |
| Sept 2015 | - | $2.05 M(+16.4%) |
| June 2015 | - | $1.76 M(-58.5%) |
| Mar 2015 | - | $4.25 M(+28.2%) |
| Dec 2014 | $3.31 M | $3.31 M(+29.0%) |
| Sept 2014 | - | $2.57 M(-61.1%) |
| June 2014 | - | $6.61 M(-45.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $12.15 M(+107.5%) |
| Dec 2013 | $5.86 M(-36.8%) | $5.86 M(-33.7%) |
| Sept 2013 | - | $8.84 M(-39.2%) |
| June 2013 | - | $14.54 M(+48.4%) |
| Mar 2013 | - | $9.80 M(+5.7%) |
| Dec 2012 | $9.27 M(+24.8%) | $9.27 M(+53.1%) |
| Sept 2012 | - | $6.05 M(-12.8%) |
| June 2012 | - | $6.94 M(+16.1%) |
| Mar 2012 | - | $5.98 M(-19.5%) |
| Dec 2011 | $7.43 M(+98.3%) | $7.43 M(+39.4%) |
| Sept 2011 | - | $5.33 M(+11.7%) |
| June 2011 | - | $4.77 M(-44.6%) |
| Mar 2011 | - | $8.62 M(+130.1%) |
| Dec 2010 | $3.75 M(+111.6%) | $3.75 M |
| Dec 2009 | $1.77 M | - |
FAQ
- What is the all time high annual accounts receivable for Merrimack Pharmaceuticals?
- What is the all time high quarterly accounts receivable for Merrimack Pharmaceuticals?
What is the all time high annual accounts receivable for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high annual accounts receivable is $9.27 M
What is the all time high quarterly accounts receivable for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high quarterly accounts receivable is $22.17 M